Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

New Approaches to Brain Tumor Therapy Consortium

Known as: NABTT 
The primary objective of the "New Approaches to Brain Tumor Therapy (NABTT)" CNS Consortium is to improve the therapeutic outcome for adults with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND The signal transduction pathways of epidermal growth factor receptor and Ras are both important in the growth of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2012
Highly Cited
2012
Cilengitide is a selective integrin inhibitor that is well tolerated and has demonstrated biologic activity in patients with… Expand
Highly Cited
2005
Highly Cited
2005
Penicillamine is an oral agent used to treat intracerebral copper overload in Wilson's disease. Copper is a known regulator of… Expand
Highly Cited
2004
Highly Cited
2004
ONYX-015 is an oncolytic virus untested as a treatment for malignant glioma. The NABTT CNS Consortium conducted a dose-escalation… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Review
2004
Review
2004
BACKGROUND Primary intraocular lymphoma (PIOL) is a subset of primary central nervous system lymphoma (PCNSL) in which lymphoma… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2004
Highly Cited
2004
The primary objective of this study was to determine the proportion of patients exhibiting a radiographic response in a cohort of… Expand
Highly Cited
2003
Highly Cited
2003
PURPOSE A multicenter, phase II study of single-agent, intravenous methotrexate in newly diagnosed non-AIDS-related primary CNS… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Highly Cited
2003
Highly Cited
2003
PURPOSE A preliminary evaluation of the efficacy of irinotecan in patients with malignant glioma demonstrated modest activity. A… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Review
1999
Review
1999
  • Brem
  • Cancer control : journal of the Moffitt Cancer…
  • 1999
  • Corpus ID: 7940738
BACKGROUND: There is extraordinary interest in developing angiosuppressive agents for cancer treatment. Several new agents appear… Expand
  • table 2
  • figure 1
  • figure 3
  • figure 5
  • table 4
1998
1998
BACKGROUND: Despite advances in neuro-imaging, neurosurgery, radiation therapy, and chemotherapy, limited progress has been made… Expand